Literature DB >> 11581610

Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart.

K Suzuki1, N J Brand, S Allen, M A Khan, A O Farrell, B Murtuza, R E Oakley, M H Yacoub.   

Abstract

OBJECTIVE: Skeletal myoblast transplantation is a promising strategy for treating end-stage heart failure. One potential problem in the development of functional, synchronously contracting grafts is the degree of intercellular communication between grafted myoblasts and host cardiomyocytes. Thus it is expected that enhancement of intercellular gap junction formation would result in improved efficiency of skeletal myoblast transplantation. In this study we investigated whether myoblasts overexpressing connexin 43, a major cardiac gap junction protein, would enhance this intercellular communication. METHODS AND
RESULTS: L6 rat skeletal myoblast cell lines overexpressing connexin 43 were generated by means of gene transfection and clonal selection. Connexin 43 overexpression of these myoblasts, which continued both in undifferentiated and differentiated states (up to 17-fold greater protein level in comparison with control-transfected myoblasts, as measured with Western blotting), was observed on cell surfaces where gap junctions should exist. Both dye microinjection and scrape loading with fluorescent dyes showed enhancement in intercellular dye transfer between connexin 43-transfected myoblasts compared with that found in control-transfected cells. Morphologically, these myoblasts fused and differentiated into multinucleated myotubes more rapidly, demonstrating a higher level of cellular creatine kinase activity as a marker of myogenic differentiation throughout the culture period compared with that of control-transfected myoblasts.
CONCLUSIONS: We have generated connexin 43-overexpressing skeletal myoblast cell lines that resulted in improved formation of functional intercellular gap junctions, which could be relevant to synchronous contraction of grafted myoblasts in the heart. In addition, these cells demonstrated more rapid differentiation, which would also be advantageous in a graft for transplantation to the heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581610     DOI: 10.1067/mtc.2001.116210

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

Review 1.  Stem cell therapies for heart disease: why do we need bioengineers?

Authors:  Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2007 Jul-Aug

2.  Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo.

Authors:  Philipp Treskes; Klaus Neef; Sureshkumar Perumal Srinivasan; Marcel Halbach; Christof Stamm; Douglas Cowan; Maximilian Scherner; Navid Madershahian; Thorsten Wittwer; Jürgen Hescheler; Thorsten Wahlers; Yeong-Hoon Choi
Journal:  J Thorac Cardiovasc Surg       Date:  2014-09-18       Impact factor: 5.209

3.  Aligned ovine diaphragmatic myoblasts overexpressing human connexin-43 seeded on poly (L-lactic acid) scaffolds for potential use in cardiac regeneration.

Authors:  Carlos Sebastián Giménez; Paola Locatelli; Florencia Montini Ballarin; Alejandro Orlowski; Ricardo A Dewey; Milagros Pena; Gustavo Abel Abraham; Ernesto Alejandro Aiello; María Del Rosario Bauzá; Luis Cuniberti; Fernanda Daniela Olea; Alberto Crottogini
Journal:  Cytotechnology       Date:  2017-11-15       Impact factor: 2.058

Review 4.  Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

Authors:  Srikanth Givvimani; Sathnur Pushpakumar; Sudhakar Veeranki; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2014-05-09       Impact factor: 2.273

5.  Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation.

Authors:  G Ciofani; L Ricotti; S Danti; S Moscato; C Nesti; D D'Alessandro; D Dinucci; F Chiellini; A Pietrabissa; M Petrini; A Menciassi
Journal:  Int J Nanomedicine       Date:  2010-04-15

6.  Preconditioning of Human Skeletal Myoblast with Stromal Cell-derived Factor-1α Promotes Cytoprotective Effects against Oxidative and Anoxic Stress.

Authors:  Ibrahim Elmadbouh; Husnain Kh Haider; Muhammad Ashraf; Juan-Carlos Chachques
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

Review 7.  Myoblast-based cell transplantation.

Authors:  Philippe Menasché
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 8.  Cardiac tissue engineering for replacement therapy.

Authors:  Wolfram-Hubertus Zimmermann; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 9.  Reprogramming cells for transplantation.

Authors:  Jonathan Leor; Alexander Battler; Robert A Kloner; Sharon Etzion
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

10.  Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium.

Authors:  Klaus Neef; Yeong-Hoon Choi; Sureshkumar Perumal Srinivasan; Philipp Treskes; Douglas B Cowan; Christof Stamm; Martin Rubach; Roland Adelmann; Thorsten Wittwer; Thorsten Wahlers
Journal:  J Thorac Cardiovasc Surg       Date:  2012-09-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.